Connecticut Settles with Generic Drug Makers Over Pricing Allegations Impacting Consumers

Connecticut Settles with Generic Drug Manufacturers

On March 17, 2026, the Connecticut Office of the Attorney General announced that additional settlements have been reached with several generic prescription drug manufacturers. This follows a series of lawsuits claiming that consumers were forced to pay unjustifiably inflated prices for generic drugs. The drug companies involved in these settlements include Bausch Health US, LLC, Bausch Health Americas, Inc., and Lannett Company, Inc.

These lawsuits emerged when state attorneys general alleged that these manufacturers colluded to fix prices on a variety of generic drugs sold across the United States. The allegations underscore that as a direct result of these actions, individuals who purchased the drugs may have paid more than necessary. Importantly, the lawsuits don't challenge the safety or efficacy of the drugs in question but focus solely on pricing strategies.

Who is Affected?

Consumers who purchased a generic prescription drug manufactured by any of the aforementioned companies between May 1, 2009, and December 31, 2019, and reside in a state that is part of the lawsuit, may be eligible for compensation. Individuals can check their eligibility for settlement benefits by visiting the dedicated website, AGGenericDrugs.com or by contacting a toll-free number.

Details of the Settlements

The settlement has created a fund for future distributions, which includes approximately $17.8 million contributed by the settling companies. Out of this, about $12.6 million is earmarked for direct payments to eligible consumers, while the rest will cover administrative costs and reimburse legal expenses incurred by the state attorneys general. However, funds will not be distributed immediately; they will be allocated according to a plan that will be approved by the court at a later date.

State attorneys general involved in the case will continue to pursue legal actions against remaining defendants, anticipating that additional funds from future settlements will enhance the present settlement fund.

How to Claim Your Benefits

While the claims process is not yet open, it is anticipated to launch at a future date. Claimants will be required to submit a form to qualify for any payments received from this settlement. Those interested in updates about when the claims process begins should register on AGGenericDrugs.com or call the specified toll-free number.

Your Rights under the Settlement

It’s essential for consumers to understand their legal rights concerning this settlement. If no action is taken, consumers will automatically be bound by the terms of the settlement. Those wishing to retain the right to file separate lawsuits against the settling defendants must officially exclude themselves no later than May 6, 2026. Additionally, comments or objections to the settlement can be filed by the same deadline, and the court will hold a hearing on May 27, 2026, to determine the final approval of the settlement terms. Consumers are welcome to attend the hearing at their own expense, though attendance is not mandatory.

For more information about the settlements, eligibility, and claiming process, consumers are encouraged to explore the resources available online or reach out via the provided contact numbers. Stay informed to ensure you can maximize your benefits from these developments affecting generic drug pricing!